ANS-014004 is under development for the treatment of solid tumor and non small cell lung cancer (NSCLC). The therapeutic candidate is administered through oral route as tablet formulation. It acts by ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Metastatic Pancreatic Cancer.

Mohali, is inviting applications for its prestigious PhD program in Biotechnology, commencing in January 2025, with research ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

Achieving biotech sovereignty will reduce dependency on foreign nations for critical products and technologies, ensuring ...

Percheron Therapeutics' board of directors has written a letter to shareholders following failure of its phase 2b trial.

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

BBGI, the biotechnology arm of energy conglomerate Bangchak Corporation, plans to supply a cleaner fuel called "bio-LNG" to ...

The year 2025 will witness India assuming critical role in the global biotechnology revolution, and the first Bio-E3 policy ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

University of York spin-out, Cizzle Biotechnology, has announced that it has appointed a new chief scientific officer (CSO).